Skip to content
GLP-1 Desk
Menu
Dispatch #426

Maven Clinic

Maven Clinic is a virtual women's and family health platform (fertility, maternity, menopause, pediatrics) used by 2,300+ employers that also runs a dedicated GLP-1 Care program.

Visit Maven ClinicAssume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we file on a provider reads the same either way.
Semaglutide
Not disclosed
Tirzepatide
Not disclosed
Coverage
Coverage not published
Brand-name
Yes

Line Maven Clinic up against its closest alternatives. Or go one-on-one: Maven Clinic vs CoreAge Rx.

Desk Score breakdown

Each of the six scored dimensions. See the methodology.

Price transparency30/100
State access24/100
Molecule range53/100
Onboarding speed66/100
Support responsiveness76/100
Licensing & trust86/100

What the Desk likes

  • Dedicated GLP-1 Care program with brand-name (FDA-approved) GLP-1 prescriptions
  • On-demand visits with metabolic and hormone-health specialists, plus nutrition and strength support
  • Integrated with broader women's, hormone, and family health care
  • LegitScript-verified; trusted by 2,300+ employers
  • Available as both an employer health benefit and a consumer self-pay option

Where points come off

  • Pricing is not published on the public site
  • Primarily distributed through employers and health plans — direct access can depend on your plan
  • US state availability for GLP-1 is not specified publicly
  • Brand-name only — no lower-cost compounded option

The Desk's briefing — C

Best for: Readers who want brand-name GLP-1 with specialist support, integrated into women's and family virtual care.

Maven Clinic ranks #426 of 498 providers scored — see #1, CoreAge Rx on the board.

Related dispatches

Everyone else on the board (18)

Pricing and verification reflect Maven Clinic's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on Maven Clinic's site. Not medical advice; see our disclosure.

← Back to The Desk